Private Equity

Updated:

Merchavia

Merchavia is a private equity firm based in Israel. It focuses on venture capital investments. The firm has a team of two staff members, including two...

Merchavia logo

Merchavia

Merchavia is a private equity firm based in Israel. It focuses on venture capital investments. The firm has a team of two staff members, including two investment professionals.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

Middle East

Country

Israel

City

Bnei Brak

Corporate office

BSR Tower No. 4, Bnei Brak, Israel

Principals

Ilan Goldstein

President

Eli Arad

CEO

Rani Lifshitz

Chairman of the Board

Dr. Eran Schenker

Medical Director

Sector focus

Digital HealthMedical Devices

Frequently asked questions

How does Merchavia source its med-tech deals?

The firm states it gives investment preference to companies related to the Cleveland Clinic, leveraging direct US hospital connections. Its scientific advisory committee includes Cleveland Diagnostics founder Dr. Arnon Chait, and the network guides deal flow toward high-potential diagnostics and medical-device startups.

What investment stages does Merchavia target?

Merchavia invests at early and growth stages, favoring companies where a value event — licensing, commercial milestone, or exit — is achievable within roughly 18 months. It does not operate blind-pool funds but makes concentrated equity investments from the Goldstein family's balance sheet.

Does Merchavia participate in fund commitments or only direct deals?

Based on its disclosed structure, Merchavia invests directly into portfolio companies rather than committing to external venture funds. The firm reviews dozens of projects annually and selects a concentrated set of eight positions.

Who controls investment decisions at Merchavia?

Ilan Goldstein, who holds a controlling interest and serves as president, leads investment direction alongside CEO Eli Arad and the board. The medical director and scientific advisory committee provide technical diligence, with particular weight given to US clinical validation.

Where does Merchavia's capital originate?

The capital comes from the Goldstein family's US-based real estate operations, which the firm describes as an exceptionally broad-scale family real estate company. The family entered Israeli public markets by acquiring a listed company for tens of millions of NIS.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Bnei Brak Private Equity profiles